Published in Oncogene on October 22, 2012
Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis. J Hepatol (2013) 1.52
Krüppel-like factors in cancer. Nat Rev Cancer (2013) 1.32
Glycogen synthase kinase 3β represses MYOGENIN function in alveolar rhabdomyosarcoma. Cell Death Dis (2014) 0.81
β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma. World J Gastroenterol (2015) 0.81
Ah Receptor Pathway Intricacies; Signaling Through Diverse Protein Partners and DNA-Motifs. Toxicol Res (Camb) (2015) 0.77
The pentapeptide Gly-Thr-Gly-Lys-Thr confers sensitivity to anti-cancer drugs by inhibition of CAGE binding to GSK3β and decreasing the expression of cyclinD1. Oncotarget (2017) 0.75
Transforming Growth Factor-β1 Increases DNA Methyltransferase 1 and 3a Expression through Distinct Post-transcriptional Mechanisms in Lung Fibroblasts. J Biol Chem (2016) 0.75
Krüppel-like factors in mammalian stem cells and development. Development (2017) 0.75
Krüppel-like factor 6 is a transcriptional activator of autophagy in acute liver injury. Sci Rep (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J (1997) 12.97
Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell (2002) 10.34
Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol (2010) 5.87
Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A (1998) 4.99
The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene (2010) 4.00
KinasePhos: a web tool for identifying protein kinase-specific phosphorylation sites. Nucleic Acids Res (2005) 3.28
KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science (2001) 3.22
Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology (2004) 2.29
Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation. J Hepatol (2006) 1.98
Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol (2010) 1.91
Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer. Gastroenterology (2004) 1.59
Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1. Cancer Res (2004) 1.57
A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. Hepatology (2010) 1.49
The Fbw7/human CDC4 tumor suppressor targets proproliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs. J Biol Chem (2010) 1.48
Krüppel-like factor-6 promotes preadipocyte differentiation through histone deacetylase 3-dependent repression of DLK1. J Biol Chem (2005) 1.46
E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor. Oncogene (2006) 1.22
A new role for the Kruppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function. Oncogene (2004) 1.20
Regulation of Kruppel-like factor 6 tumor suppressor activity by acetylation. Cancer Res (2005) 1.20
In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma. Oncogene (2007) 1.12
Transcriptional activation of the human inducible nitric-oxide synthase promoter by Kruppel-like factor 6. J Biol Chem (2003) 1.11
Nucleo-cytoplasmic localization domains regulate Krüppel-like factor 6 (KLF6) protein stability and tumor suppressor function. PLoS One (2010) 0.99
KLF6 degradation after apoptotic DNA damage. FEBS Lett (2006) 0.93
Tumor suppressor activity of KLF6 mediated by downregulation of the PTTG1 oncogene. FEBS Lett (2010) 0.83
Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas. J Zhejiang Univ Sci B (2006) 0.81
Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut (2005) 5.39
Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci U S A (1985) 4.76
KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science (2001) 3.22
p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med (1998) 2.91
Identification of desmoglein, a constitutive desmosomal glycoprotein, as a member of the cadherin family of cell adhesion molecules. Eur J Cell Biol (1990) 2.77
Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol (1992) 2.72
An abundant and ubiquitous homo-oligomeric ring-shaped ATPase particle related to the putative vesicle fusion proteins Sec18p and NSF. EMBO J (1990) 2.60
An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res (2000) 2.36
Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. Anal Biochem (1987) 2.31
Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J Gastroenterol Hepatol (1999) 2.02
Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. Proc Natl Acad Sci U S A (1998) 2.02
Purification and characterization of eight class 5 outer membrane protein variants from a clone of Neisseria meningitidis serogroup A. J Exp Med (1988) 1.98
Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. J Clin Invest (1989) 1.95
Faculty triage shortens emergency department length of stay. Acad Emerg Med (2001) 1.91
Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest (1994) 1.91
Gastrointestinal Kaposi's sarcoma in patients with acquired immunodeficiency syndrome. Endoscopic and autopsy findings. Gastroenterology (1985) 1.90
DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. J Clin Invest (2001) 1.89
Antimicrobial resistance in Salmonella enterica serovar Heidelberg isolates from retail meats, including poultry, from 2002 to 2006. Appl Environ Microbiol (2008) 1.85
Hepatic fibrosis. Pathogenesis and principles of therapy. Clin Liver Dis (2001) 1.78
Site-specific recombination of yeast 2-micron DNA in vitro. Proc Natl Acad Sci U S A (1983) 1.66
Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest (1993) 1.63
Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. J Clin Invest (1992) 1.62
Transcriptional repression of the cystic fibrosis transmembrane conductance regulator gene, mediated by CCAAT displacement protein/cut homolog, is associated with histone deacetylation. J Biol Chem (1999) 1.61
Collagen measured in primary cultures of normal rat hepatocytes derives from lipocytes within the monolayer. J Clin Invest (1988) 1.60
The FLP protein of the 2-micron plasmid of yeast. Purification of the protein from Escherichia coli cells expressing the cloned FLP gene. J Biol Chem (1985) 1.59
Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex. Am J Physiol Gastrointest Liver Physiol (2000) 1.58
Practolol in acute myocardial infarction. Acta Med Scand Suppl (1976) 1.57
Molecular regulation of hepatic fibrogenesis. J Hepatol (1998) 1.56
Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis. J Exp Med (1986) 1.56
RNA splicing mutation in an aberrantly rearranged immunoglobulin lambda I gene. Proc Natl Acad Sci U S A (1981) 1.55
Systemic sarcoidosis with refractory ventricular tachycardia and heart failure. Br Heart J (1978) 1.50
The ecology of childhood overweight: a 12-year longitudinal analysis. Int J Obes (Lond) (2007) 1.48
Natural history of isolated bundle branch block. Am J Cardiol (1996) 1.46
Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. A study of 177 patients. Arch Dermatol (1996) 1.46
Expression and role of Bcl-xL in human hepatocellular carcinomas. Hepatology (2001) 1.46
Testing a core emotion-regulation prediction: does early attentional persistence moderate the effect of infant negative emotionality on later development? Child Dev (2001) 1.43
Pharmacological, toxicologic, and microbiological considerations in the choice of initial antibiotic therapy for serious infections in patients with cirrhosis of the liver. Clin Infect Dis (1994) 1.41
Mobile coronary care. Br Heart J (1972) 1.39
Alcohol, amines, and alkaloids: a possible biochemical basis for alcohol addiction. Science (1970) 1.39
Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue. J Virol (2000) 1.39
Identification of a widespread nuclear actin binding protein. Nature (1989) 1.38
Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity. Biochem J (1992) 1.35
Duration of action of beta-blocking drugs. Br Med J (1973) 1.33
Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma. Hepatology (1992) 1.30
Transcriptional activation of urokinase by the Krüppel-like factor Zf9/COPEB activates latent TGF-beta1 in vascular endothelial cells. Blood (2000) 1.30
Genetic dissociation of the encapsidation and reverse transcription functions in the 5' R region of human immunodeficiency virus type 1. J Virol (1999) 1.29
Mobile coronary care. Lancet (1970) 1.29
Immunolocalization of laminin in normal rat liver and biosynthesis of laminin by hepatic lipocytes in primary culture. Gastroenterology (1988) 1.29
Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis. Hepatology (2001) 1.29
Regulation of cytokine mRNA expression in lipopolysaccharide-stimulated human macrophages. Arch Surg (1993) 1.27
Is liver fibrosis reversible? N Engl J Med (2001) 1.26
Genetic recombination of bacteriophage T7 DNA in vitro. Proc Natl Acad Sci U S A (1976) 1.25
Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. Vaccine (2000) 1.23
E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor. Oncogene (2006) 1.22
Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients. Cancer (1994) 1.22
Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene (1998) 1.22
In vitro systems for genetic recombination of the DNAs of bacteriophage T7 and yeast 2-micron circle. Cold Spring Harb Symp Quant Biol (1984) 1.21
Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension. Eur J Gastroenterol Hepatol (1999) 1.19
Purification and characterization of acylation stimulating protein. J Biol Chem (1989) 1.17
Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma. Cancer Res (2001) 1.16
Early genes induced in hepatic stellate cells during wound healing. Gene (1997) 1.15
Functional outcomes following treatment for advanced laryngeal cancer. Part I--Voice preservation in advanced laryngeal cancer. Part II--Laryngectomy rehabilitation: the state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group. Ann Otol Rhinol Laryngol Suppl (1998) 1.15
Regulation of the homeodomain CCAAT displacement/cut protein function by histone acetyltransferases p300/CREB-binding protein (CBP)-associated factor and CBP. Proc Natl Acad Sci U S A (2000) 1.15
Antimicrobial resistance of Campylobacter isolates from retail meat in the United States between 2002 and 2007. Appl Environ Microbiol (2010) 1.14
Activation of beta2-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure. Circulation (1999) 1.12
In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma. Oncogene (2007) 1.12
Connective tissue biology and hepatic fibrosis: report of a conference. Hepatology (1990) 1.12
Amino acid sequence of bovine muzzle epithelial desmocollin derived from cloned cDNA: a novel subtype of desmosomal cadherins. Differentiation (1991) 1.11
Early mobilisation and discharge of patients with acute myocardial infarction. Lancet (1972) 1.10
Selection of patients for early discharge after acute myocardial infarction. Br Heart J (1974) 1.10
Formation of extracellular matrix in normal rat liver: lipocytes as a major source of proteoglycan. Gastroenterology (1988) 1.10
Transcriptional regulation in hepatic stellate cells. Semin Liver Dis (2001) 1.10
CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells. Hepatology (1999) 1.09
Percutaneous transluminal coronary angioplasty in unstable angina: comparison with stable angina. Br Heart J (1986) 1.09
The Krüppel-like transcriptional factors Zf9 and GKLF coactivate the human keratin 4 promoter and physically interact. FEBS Lett (2000) 1.08
Antifibrotic agents for liver disease. Am J Transplant (2006) 1.08
Ethanol and arachidonic acid increase alpha 2(I) collagen expression in rat hepatic stellate cells overexpressing cytochrome P450 2E1. Role of H2O2 and cyclooxygenase-2. J Biol Chem (2000) 1.07
A trans-receptor mechanism for infection of CD4-negative cells by human immunodeficiency virus type 1. Curr Biol (1999) 1.07
Diamorphine-induced attack of paroxysmal hypertension in phaeochromocytoma. Br Med J (1974) 1.06
Cardiac catheterisation with 5 French catheters. Br Heart J (1990) 1.05
Transcription of cystic fibrosis transmembrane conductance regulator requires a CCAAT-like element for both basal and cAMP-mediated regulation. J Biol Chem (1995) 1.05
An imaging filter for biological applications. Ultramicroscopy (1995) 1.04
Complete amino acid sequence of the epidermal desmoglein precursor polypeptide and identification of a second type of desmoglein gene. Eur J Cell Biol (1991) 1.04
Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients. J Infect Dis (1997) 1.04
Reversible severe thrombocytopaenia associated with captopril therapy. Ir Med J (1986) 1.03
Control of T4 endonuclease IV by the D2a region of bacteriophage T4. Virology (1973) 1.02
Immunoglobulin G, A, and M--clonal restriction in multiple sclerosis cerebrospinal fluid and serum--analysis by two-dimensional electrophoresis. Clin Immunol Immunopathol (1985) 1.02
Hepatic lipocytes: a major target for endothelin-1. J Hepatol (1995) 1.01
Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: evidence for a two-hit mechanism of NF2 inactivation. Genes Chromosomes Cancer (1999) 1.00
Point mutants in the D2a region of bacteriophage T4 fail to induce T4 endonuclease IV. J Virol (1974) 0.99
Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma. J Hepatol (1996) 0.98
Hepatic side-effects of antibiotics. J Antimicrob Chemother (1994) 0.97
Cardiac arrhythmias after intravenous cimetidine. N Engl J Med (1981) 0.96
Regulation of types I, III, and IV procollagen mRNA synthesis in glucocorticoid-mediated intestinal development. J Biol Chem (1987) 0.96
Myocardial infarction in the elderly. Lancet (1972) 0.95
Transventricular pressure-velocity wave propagation in diastole: adherence to the Moens-Korteweg equation. Physiol Meas (1998) 0.95